Swedish Orphan Biovitrum AB (Sobi)

Sobi is an international biopharmaceutical company specializing in innovative treatments for rare diseases. Committed to transforming patient lives, they focus on developing therapies in haematology and haemophilia, supported by a strong R&D pipeline and global collaborations.